Nextech Invest’s Avalo Therapeutics AVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.7M Buy
+766,000
New +$14.1M 0.53% 13

Other funds holding AVTX

Nextech Invest's AVTX Position: Q3 2026 in Review

Nextech Invest opened a new position in Avalo Therapeutics (AVTX) in Q3 2026: 766,000 shares worth $11.7M. The stake represents 0.53% of the portfolio and ranks #13 among its holdings.

148 funds tracked by Wall St. Rank hold AVTX as of Q3 2026.

  • Nextech Invest held 766,000 shares of Avalo Therapeutics worth $11.7M as of Q3 2026.
  • Avalo Therapeutics was a new Nextech Invest position in Q3 2026.
  • Avalo Therapeutics made up 0.53% of Nextech Invest's portfolio in Q3 2026, its #13 holding.
  • 148 funds tracked by Wall St. Rank held Avalo Therapeutics as of Q3 2026.

Based on Nextech Invest's 13F filing for Q3 2026, filed 16 Nov 2026.